Ontology highlight
ABSTRACT:
PROVIDER: PRJNA608091 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:The purpose of this experiment is to investigate the chemical composition of the plant, with the plant samples collected in Hainan, China.
2025-03-04 | MSV000097227 | MassIVE
Project description:We attempted to screen and identify new plasma EV delivered microRNA can simultaneously diagnose AA, early CRC and advanced CRC in healthy people. We employed microRNA deep sequencing assay for the primary screen and performed TaqMan microRNA assay for further test and validation. Through stepwise screen and validation in two independent cohorts (cohort I: n=75, cohort II: n=104), we demonstrated that plasma EV-delivered miR-185-5p is a potential indicator of AA and CRC in Chinese patients. In the supplementary phase, we also preliminarily proved that miR-185-5p can promote the development of CRC in vivo and in vitro.
2023-09-11 | GSE220445 | GEO
Project description:Transcription profiling of human blood eosinophils in eosinophilic asthma patients compared to healthy individuals
2025-01-23 | E-MTAB-4660 | ExpressionAtlas
Project description:RNA-seq of whole blood samples from human visceral leishmaniasis compared to samples from healthy uninfected controls
2025-01-23 | E-MTAB-4902 | ExpressionAtlas
Project description:Osteoblast primary cell lines (OBS) from Shwachman-Diamond Syndrome (SDS) patients compared to healthy donors by one color transciptome array
2025-01-23 | E-MTAB-9397 | ExpressionAtlas
Project description:Extracellular vesicles (EVs) are valuable sources for the discovery of useful cancer biomarkers. This study explores the potential usefulness of tumor cell-derived EV membrane proteins as plasma biomarkers for early detection of colorectal cancer (CRC). EVs were isolated from the culture supernatants of four CRC cell lines by ultracentrifugation, and their protein profiles were analyzed by LC-MS/MS. Bioinformatics analysis of identified proteins revealed 518 EV membrane proteins in common among at least three CRC cell lines. We next used accurate in-clusion mass screening (AIMS) in parallel with iTRAQ-based quantitative proteomic analysis to highlight candidate proteins and validated their presence in pooled plasma-generated EVs from 30 healthy controls and 30 CRC patients. From these, we chose 14 potential EV-derived targets for further quantification by targeted MS assay in a separate individual cohort comprising of 73 CRC and 80 healthy subjects. Quantitative analyses revealed significant increases in ADAM10, CD59 and TSPAN9 levels (2.19- to 5.26-fold, p <0.0001) in plasma EVs from CRC patients, with AUC values of 0.83, 0.95 and 0.87, respectively. Higher EV CD59 levels were significantly corre-lated with distant metastasis (p = 0.0475), and higher EV TSPAN9 levels were significantly asso-ciated with lymph node metastasis (p = 0.0011), distant metastasis at diagnosis (p = 0.0104) and higher TNM stage (p = 0.0065). A two-marker panel consisting of CD59 and TSPAN9 outper-formed the conventional marker CEA in discriminating CRC and stage I/II CRC patients from healthy controls, with AUC values of 0.98 and 0.99, respectively. Our results identify EV mem-brane proteins in common among CRC cell lines and altered plasma EV protein profiles in CRC patients, and suggest plasma EV CD59 and TSPAN9 as a novel biomarker panel for detecting early-stage CRC.
2023-03-11 | PXD038871 | Pride
Project description:Transcriptional profiling of primary human alveolar macrophages challenged with Streptococcus pneumoniae from patients with chronic obstructive pulmonary disease compared to healthy donors
2025-01-23 | E-MTAB-6491 | ExpressionAtlas